Lexicon Pharmaceuticals, Inc.
LXRX· Nasdaq
LXRXLexicon Pharmaceuticals, Inc.
Filed Mar 7, 2014 · 10-K · 66 days after period end · 0001062822-14-000009
| Metric | Q4 2012 | Q4 2011 | Q4 2010 | Q4 2009dderived from reported figures |
|---|---|---|---|---|
| Revenue | $1.41M | $218.00K | $343.00K | — |
| Net Income | -$17.41M | -$24.87M | -$33.85M | — |
| EPS Diluted | -$0.03 | -$0.05 | -$0.10 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lexicon Pharmaceuticals, Inc. · CIK 1062822 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Mar 7, 2014 · 66 d after period end
